Effect of Different Antitumor Regimens on Incidence and Severity of Corona Virus 
Disease 2019 Pneumonia in Lung Cancer Patients: 
A Single-center Retrospective Study

Wanjun LU; Jiawen LV; Qin WANG; Yanwen YAO; Dong WANG; Jiayan CHEN; Guannan WU; Xiaoling GU; Huijuan LI; Yajuan CHEN; Hedong HAN; Tangfeng LV; Yong SONG; Ping ZHAN.
Chinese Journal of Lung Cancer ; (12): 429-438, 2023.
Artículo en Zh | WPRIM | ID: wpr-982175

Documentos relacionados

  1. [Effect of Different Antitumor Regimens on Incidence and Severity of Corona Virus 
Disease 2019 Pneumonia in Lung Cancer Patients: 
A Single-center Retrospective Study].
  2. Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis.
  3. Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease.
  4. Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.
  5. Association of pre-existing lung interstitial changes with immune-related pneumonitis in patients with non-small lung cancer receiving immunotherapy.
  6. Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer - A multicenter observational analysis.
  7. Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer.
  8. Dynamic immune signatures of patients with advanced non-small-cell lung cancer for infection prediction after immunotherapy.
  9. A dynamic nomogram predicting symptomatic pneumonia in patients with lung cancer receiving thoracic radiation.
  10. Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.